The CD34+CD38− compartment has since served as the primary focus for LSC identification in AML, although subsequent studies demonstrate that other blast fractions harbor LSC activity, albeit at reduced frequencies (Eppert et al., 2011; Ng et al., 2016). The gene discussed is CD34; the disease is acute myeloid leukemia.